Indore News: Pharma Units Must Upgrade To Meet New Norms, Says Dy Drug Controller Gourav Rohilla
Gourav Rohilla, Deputy Drug Controller, urged pharmaceutical units to upgrade operations to comply with new regulations, assuring departmental support. He spoke at the inaugural session of the three-day Indore Pharma Lab & Chemical Expo at the Brilliant Convention Center. The event saw participation from numerous industry representatives.

Indore News: Pharma Units Must Upgrade To Meet New Norms, Says Dy Drug Controller Gourav Rohilla |
Indore (Madhya Pradesh): Gourav Rohilla, Deputy Drug Controller of the Central Drug Department, has stated that it is time for the pharmaceutical units to upgrade themselves. As companies upgrade, they can take their businesses to a higher level. He assured that the department would provide all necessary support.
Rohilla said this while addressing the inaugural session of a three-day Indore Pharma Lab and Chemical Expo that commenced at the Brilliant Convention Center from Thursday. Special guest were Dharmendra Bigonia, licensing authority of the Madhya Pradesh Drug Department. JP Mulchandani, president of the Basic Drug Dealers Association, Paresh Chawla and Dr. Darshan Kataria were also the distinguished guests of the programme.
On this occasion, Mulchandani, said that the city has become a major hub for the pharmaceutical sector, where significant business is conducted both domestically and internationally by domestic, general medicine, and export-oriented units. Under government policies and regulations, all factories now need to upgrade their companies to meet government norms.
Companies that upgrade themselves according to the new rules will certainly benefit in the future. From drug quality to documentation, whether it's the domestic market, the generic market or the export market, drug manufacturers will benefit from these regulations.
ALSO READ
On this occasion, a large number of representatives from the pharma sector were present, including Sudhir Bora, Ajay Dasundi, Anil Sabarwal, Dr Subhash Rizwani, Anil Sanghvi, Himanshu Shah, Abhijeet Motiwale, Nirmal Bagri, Kamal Bilala, Pritesh Jain, Kulbir Singh Khalsa, Manish Dawani, Manish Shah, Anil Chimnani, Sonu Rajdev, and Vijay Mulchandani.
RECENT STORIES
-
Ceigall India Arm Emerges L1 Bidder For ₹207 Crore Punjab Urban Street Projects -
Indore News: Congress Protests Outside Civic Chief Office Against MOS Tax -
'God's Servant, Joined To God': Iran Confirms Death Of Security Chief Ali Larijani In Israeli... -
SBI Raises ₹ 6,051 Crore Via Basel III Tier 2 Bonds At 7.05% Coupon -
Subex Secures €2.7 Million EAM Deal With North African Telecom Operator
